the Chief Development and Medical Officer
Alastair Benbow is the Chief Development and Medical Officer at Norgine. Alastair is a physician with over 25 years of experience in the pharmaceutical industry. Prior to joining Norgine in September 2016, Alastair worked for a number of companies including Fisons, Genentech, Synthelabo and spent 12 years working at GlaxoSmithKline (GSK). During his time at GSK, he held positions as UK Medical Director, Head of European Government Affairs, Head of Psychiatry Development, European Medical Director and SVP Global Safety and Pharmacovigilance and EU QPPV. For three years, he held the role of Executive Director for the non-profit organisation, the European Brain Council and for three years he was Chief Medical Officer at Kinapse, where he led the Regulatory, Safety and Medical functions. He is a fellow of the Royal College of Physicians of Ireland and a Fellow of the Faculty of Pharmaceutical Medicine. In 2017 Alastair was appointed Chair of the Ethics and Practice Committee of the Faculty of Pharmaceutical Medicine.
sales, marketing, market research, licensing, business development and general management.